Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine-containing quadruple therapy for H. pylori rescue
NCT03609892Phase 4Completed
- Sponsor
- Xijing Hospital of Digestive Diseases
- Start
- Aug 2018
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of berberine in Helicobacter pylori infection, sponsored by Xijing Hospital of Digestive Diseases. Started Aug 2018; status: completed.
02
Drugs
berberine
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT03609892.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609892.